Search

Towards a Better Understanding of the Life Cycle of Trypanosoma copemani

To understand the biology and life cycle of Trypanosoma copemani, the growth requirements, and kinetics of infection of two new genotypes were investigated

Predictors of distress and poorer quality of life in High Grade Glioma patients

To determine High Grade Glioma patients' levels of distress and quality of life during combined chemoradiotherapy, explore predictors of distress and quality...

Sun exposure and vitamin D status as northeast asian migrants become acculturated to life in Australia

Targeted public health approaches are required to manage the high prevalence of vitamin D deficiency in migrants retaining a traditional lifestyle

Hospital utilization, costs and mortality rates during the first 5 years of life

Long-term physical and mental health outcomes of ART singletons are generally reassuring. There is a scarcity of information on health service utilization...

Breastfeeding in the first hour of life protects against neonatal mortality

Breastfeeding within the first hour of life has been shown to reduce high neonatal mortality by 22%.

The Kids researchers help quantify global impact of life-saving vaccines

Researchers at The Kids Research Institute Australia have helped map the global impact of life saving vaccines to mark the 50-year anniversary of the Expanded Programme on Immunisation (EPI).

Sun safe app - Be part of a real life research project

The Kids Research Institute Australia researchers are developing a mobile phone app that will give you tailored advice for your skin type.

Use of administrative record linkage to examine patterns of universal early childhood health and education service use from birth to Kindergarten (age 4 years) and developmental vulnerability in the Preparatory Year (age 5 years) in Tasmania, Australia

In Australia, the health and education sectors provide universal early childhood services for the same population of children. Therefore, there is a strong imperative to view service use and outcomes through a cross-sectoral lens to better understand and address the service needs of young children and their families.

Is it still correct to differentiate between early and very early onset psychosis?

Larger samples of patients are needed to better understand if the differentiation between very early onset psychosis and early onset psychosis is justified

Fc-Engineered B7-H3 Antibody with Prolonged Serum Half-Life for Enhanced Cancer Therapy

Monoclonal antibodies are revolutionizing the landscape of current cancer treatment, bringing hope to patients with incurable cancers. B7-H3 (CD276) is an attractive therapeutic target for antibody-based therapy due to its low or absent expression in normal tissues and high expression in various types of tumors, including prostate cancer, pancreatic cancer, and high-mortality esophageal squamous cell carcinoma (ESCC). In recent years, various B7-H3-targeting antibodies have been developed for cancer treatment, with a few making their way to clinical trials.